A Composite Cytology-Histology Endpoint Allows a More Accurate Estimate of Anal High-Grade Squamous Intraepithelial Lesion Prevalence
Dorothy A Machalek, I Mary Poynten, Fengyi Jin, Richard J Hillman, David J Templeton, Carmella Law, Jennifer M Roberts, Sepehr N Tabrizi, Suzanne M Garland, Annabelle Farnsworth, Christopher K Fairley, Andrew E Grulich
Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2016
Awarded by National Health and Medical Research Council Program Grant
Awarded by Cancer Council New South Wales Strategic Research Partnership Program Grant
The SPANC study was funded by a National Health and Medical Research Council Program Grant (Sexually transmitted infections: Causes, consequences and interventions Grant #568971; to A.E. Grulich and C.K. Fairley) and a Cancer Council New South Wales Strategic Research Partnership Program Grant (preventing morbidity and mortality from anal cancer grant #13 11; to A.E. Grulich, I.M. Poynten, F. Jin, R.J. Hillman, D.J. Templeton, S.N. Tabrizi, S.M. Garland, A. Farnsworth, and C.K. Fairley). Cytologic testing materials were provided by Hologic Pty Ltd. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales, and funded by the Australian Government of Health and Ageing.